isirv Antiviral Group
AVG Membership
Membershipof the isirv-AVG is open to all members of isirv. To assist participation in the various activities and potential contribution to information/website content, members are asked to indicate their particular interests/areas of expertise in relation to the list ofAreas of Interest(below).
Please contact us to discuss membership of isirv-AVG. Members will receive regular communication on features of interest to the group.
Areas of interest (including principal activities):
| A. Clinical use of antivirals: | Clinical use |
| Guidance/advice (in relation to Public Health) | |
| Current developments (clinical trials) | |
| B. Resistance emergence: | Resistance monitoring |
| Characteristics of resistant mutants | |
| Resistant virus panel (update and distribution) | |
| Methodology (standardisation; analysis) | |
| Molecular mechanisms of resistance | |
| Animal studies (clinical significance) | |
| C. Antiviral development (pre-clinical): | Current developments |
| Novel targets | |
| Therapeutic antibodies | |
| Molecular mechanisms of action | |
| Animal studies (in vivo efficacy) | |
| D. Information exchange/ education: | Website organization/content |
| Meetings | |
| Guidance/advice | |
| Newsletter (6 monthly) |
|
